One- to three-year outcome for 14 neonatal survivors of extracorporeal membrane oxygenation

A. F. Andrews, C. A. Nixon, R. E. Cilley, D. W. Roloff, R. H. Bartlett

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Extracorporeal membrane oxygenation, using venoarterial or venovenous perfusion, is a safe and effective procedure in the term or near-term infant with life-threatening respiratory failure. Without extracorporeal membrane oxygenation, due to the severity of their disease, these children are at high risk for neurologic damage, chronic lung disease, and death. Because survival is not expected without extracorporeal membrane oxygenation therapy, there is no corresponding control group to which these survivors may be compared. In this report, we reviewed the outcome at 1 to 3 years in the first 14 survivors of extracorporeal membrane oxygenation treated at our institution. Seven of 14 neonatal extracorporeal membrane oxygenation survivors (50%) were normal or near normal at between 1 and 3 years of age. Ten (71%) had normal mental ability. We conclude that in neonates with high mortality risk from respiratory failure, near-normal growth and development can be expected in the majority who survive with extracorporeal membrane oxygenation treatment.

Original languageEnglish (US)
Pages (from-to)692-698
Number of pages7
JournalPediatrics
Volume78
Issue number4
StatePublished - Dec 30 1986

Fingerprint

Extracorporeal Membrane Oxygenation
Survivors
Respiratory Insufficiency
Growth and Development
Nervous System
Lung Diseases
Chronic Disease
Perfusion
Newborn Infant
Control Groups
Survival
Mortality
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Andrews, A. F., Nixon, C. A., Cilley, R. E., Roloff, D. W., & Bartlett, R. H. (1986). One- to three-year outcome for 14 neonatal survivors of extracorporeal membrane oxygenation. Pediatrics, 78(4), 692-698.
Andrews, A. F. ; Nixon, C. A. ; Cilley, R. E. ; Roloff, D. W. ; Bartlett, R. H. / One- to three-year outcome for 14 neonatal survivors of extracorporeal membrane oxygenation. In: Pediatrics. 1986 ; Vol. 78, No. 4. pp. 692-698.
@article{7628bdaef89c432e97413b0f71e7e500,
title = "One- to three-year outcome for 14 neonatal survivors of extracorporeal membrane oxygenation",
abstract = "Extracorporeal membrane oxygenation, using venoarterial or venovenous perfusion, is a safe and effective procedure in the term or near-term infant with life-threatening respiratory failure. Without extracorporeal membrane oxygenation, due to the severity of their disease, these children are at high risk for neurologic damage, chronic lung disease, and death. Because survival is not expected without extracorporeal membrane oxygenation therapy, there is no corresponding control group to which these survivors may be compared. In this report, we reviewed the outcome at 1 to 3 years in the first 14 survivors of extracorporeal membrane oxygenation treated at our institution. Seven of 14 neonatal extracorporeal membrane oxygenation survivors (50{\%}) were normal or near normal at between 1 and 3 years of age. Ten (71{\%}) had normal mental ability. We conclude that in neonates with high mortality risk from respiratory failure, near-normal growth and development can be expected in the majority who survive with extracorporeal membrane oxygenation treatment.",
author = "Andrews, {A. F.} and Nixon, {C. A.} and Cilley, {R. E.} and Roloff, {D. W.} and Bartlett, {R. H.}",
year = "1986",
month = "12",
day = "30",
language = "English (US)",
volume = "78",
pages = "692--698",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "4",

}

Andrews, AF, Nixon, CA, Cilley, RE, Roloff, DW & Bartlett, RH 1986, 'One- to three-year outcome for 14 neonatal survivors of extracorporeal membrane oxygenation', Pediatrics, vol. 78, no. 4, pp. 692-698.

One- to three-year outcome for 14 neonatal survivors of extracorporeal membrane oxygenation. / Andrews, A. F.; Nixon, C. A.; Cilley, R. E.; Roloff, D. W.; Bartlett, R. H.

In: Pediatrics, Vol. 78, No. 4, 30.12.1986, p. 692-698.

Research output: Contribution to journalArticle

TY - JOUR

T1 - One- to three-year outcome for 14 neonatal survivors of extracorporeal membrane oxygenation

AU - Andrews, A. F.

AU - Nixon, C. A.

AU - Cilley, R. E.

AU - Roloff, D. W.

AU - Bartlett, R. H.

PY - 1986/12/30

Y1 - 1986/12/30

N2 - Extracorporeal membrane oxygenation, using venoarterial or venovenous perfusion, is a safe and effective procedure in the term or near-term infant with life-threatening respiratory failure. Without extracorporeal membrane oxygenation, due to the severity of their disease, these children are at high risk for neurologic damage, chronic lung disease, and death. Because survival is not expected without extracorporeal membrane oxygenation therapy, there is no corresponding control group to which these survivors may be compared. In this report, we reviewed the outcome at 1 to 3 years in the first 14 survivors of extracorporeal membrane oxygenation treated at our institution. Seven of 14 neonatal extracorporeal membrane oxygenation survivors (50%) were normal or near normal at between 1 and 3 years of age. Ten (71%) had normal mental ability. We conclude that in neonates with high mortality risk from respiratory failure, near-normal growth and development can be expected in the majority who survive with extracorporeal membrane oxygenation treatment.

AB - Extracorporeal membrane oxygenation, using venoarterial or venovenous perfusion, is a safe and effective procedure in the term or near-term infant with life-threatening respiratory failure. Without extracorporeal membrane oxygenation, due to the severity of their disease, these children are at high risk for neurologic damage, chronic lung disease, and death. Because survival is not expected without extracorporeal membrane oxygenation therapy, there is no corresponding control group to which these survivors may be compared. In this report, we reviewed the outcome at 1 to 3 years in the first 14 survivors of extracorporeal membrane oxygenation treated at our institution. Seven of 14 neonatal extracorporeal membrane oxygenation survivors (50%) were normal or near normal at between 1 and 3 years of age. Ten (71%) had normal mental ability. We conclude that in neonates with high mortality risk from respiratory failure, near-normal growth and development can be expected in the majority who survive with extracorporeal membrane oxygenation treatment.

UR - http://www.scopus.com/inward/record.url?scp=0022494072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022494072&partnerID=8YFLogxK

M3 - Article

C2 - 2429249

AN - SCOPUS:0022494072

VL - 78

SP - 692

EP - 698

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 4

ER -

Andrews AF, Nixon CA, Cilley RE, Roloff DW, Bartlett RH. One- to three-year outcome for 14 neonatal survivors of extracorporeal membrane oxygenation. Pediatrics. 1986 Dec 30;78(4):692-698.